Schedule of Warrants Activity (Details) - Warrant [Member] - shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Warrants outstanding, beginning balance | 303,725 | 534,674 |
| Weighted average exercise price, beginning balance | 18.34 | 18.34 |
| Warrants granted | 229,268 | |
| Weighted average exercise price, warrants granted | 8.09 | |
| Warrants, forfeited | (18,107) | (460,217) |
| Weighted average exercise price, warrants forfeited | 17.16 | 18.31 |
| Weighted average remaining contractual term, ending | 1 year 6 months | |
| Warrants outstanding, ending balance | 285,618 | |
| Weighted average exercise price, ending balance | 10.25 | |
| Weighted average remaining contractual term, ending | 10 months 24 days | |
| X | ||||||||||
- Definition Number of warrants forfeited weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Number of warrants grants in weighted average exercise price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of warrants outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Number of warrants outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|